Statins, Diabetes Risk, and Natural Cardiovascular Protection: Evidence-Based Guide to Cholesterol, Diet, Fibrinolytic Enzymes, and Heart Disease Prevention (2026)
Cardiovascular disease (CVD) remains the leading cause of death worldwide, responsible for nearly 18 million deaths each year . For decades, cardiovascular prevention strategies focused primarily on one goal: lowering LDL cholesterol . This approach led to the widespread use of statins, which are now among the most prescribed medications globally. Statins have saved millions of lives by reducing the risk of heart attack and stroke. However, modern research has revealed a more complex picture. Cardiovascular disease is now understood as a multifactorial cardiometabolic disorder involving inflammation, insulin resistance, endothelial dysfunction, and thrombosis. At the same time, studies have found that statins may slightly increase the risk of type 2 diabetes , especially in individuals with metabolic risk factors. Meanwhile, growing interest has emerged in integrative approaches to cardiovascular prevention , including dietary strategies, nutraceuticals, and natural fibrinolytic enzym...